Computational Drug Discovery Market, Global Outlook and Forecast 2023-2029

Report ID: MMG119686 | Category: Service & Software | Pages: 69 | Format: PDF | Published Date: July 12,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Computational Drug Discovery/Computer-Aided Drug Discovery is an effective strategy for accelerating and economizing drug discovery and development process. Because of the dramatic increase in the availability of biological macromolecule and small molecule information, the applicability of computational drug discovery has been extended and broadly applied to nearly every stage in the drug discovery and development workflow, including target identification and validation, lead discovery and optimization and preclinical tests. Over the past decades, computational drug discovery methods such as molecular docking, pharmacophore modeling and mapping, de novo design, molecular similarity calculation and sequence-based virtual screening have been greatly improved.
This report aims to provide a comprehensive presentation of the global market for Computational Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Drug Discovery. This report contains market size and forecasts of Computational Drug Discovery in global, including the following market information:
Global Computational Drug Discovery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Computational Drug Discovery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Structure-based Drug Design (SBDD) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Computational Drug Discovery include AMRI, Charles River, Schrödinger, Evotec, Bayers, GVK Biosciences, AstraZeneca, BioDuro and BOC Sciences, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Computational Drug Discovery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Computational Drug Discovery Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Computational Drug Discovery Market Segment Percentages, by Type, 2022 (%)
    Structure-based Drug Design (SBDD)
    Ligand-based Drug Design (LBDD)
    Sequence-based Approaches
Global Computational Drug Discovery Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Computational Drug Discovery Market Segment Percentages, by Application, 2022 (%)
    Oncological Disorders
    Neurological Disorders
    Immunological Disorders
    Infectious Diseases
    Others
Global Computational Drug Discovery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Computational Drug Discovery Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Computational Drug Discovery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Computational Drug Discovery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    AMRI
    Charles River
    Schrödinger
    Evotec
    Bayers
    GVK Biosciences
    AstraZeneca
    BioDuro
    BOC Sciences
    Aris Pharmaceuticals
    ChemDiv
    RTI International
    XRQTC
    Pharmaron
Outline of Major Chapters:
Chapter 1: Introduces the definition of Computational Drug Discovery, market overview.
Chapter 2: Global Computational Drug Discovery market size in revenue.
Chapter 3: Detailed analysis of Computational Drug Discovery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Computational Drug Discovery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Computational Drug Discovery Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Computational Drug Discovery Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Computational Drug Discovery Overall Market Size
    2.1 Global Computational Drug Discovery Market Size: 2022 VS 2029
    2.2 Global Computational Drug Discovery Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Computational Drug Discovery Players in Global Market
    3.2 Top Global Computational Drug Discovery Companies Ranked by Revenue
    3.3 Global Computational Drug Discovery Revenue by Companies
    3.4 Top 3 and Top 5 Computational Drug Discovery Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Computational Drug Discovery Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Computational Drug Discovery Players in Global Market
        3.6.1 List of Global Tier 1 Computational Drug Discovery Companies
        3.6.2 List of Global Tier 2 and Tier 3 Computational Drug Discovery Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Computational Drug Discovery Market Size Markets, 2022 & 2029
        4.1.2 Structure-based Drug Design (SBDD)
        4.1.3 Ligand-based Drug Design (LBDD)
        4.1.4 Sequence-based Approaches
    4.2 By Type - Global Computational Drug Discovery Revenue & Forecasts
        4.2.1 By Type - Global Computational Drug Discovery Revenue, 2018-2023
        4.2.2 By Type - Global Computational Drug Discovery Revenue, 2024-2029
        4.2.3 By Type - Global Computational Drug Discovery Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Computational Drug Discovery Market Size, 2022 & 2029
        5.1.2 Oncological Disorders
        5.1.3 Neurological Disorders
        5.1.4 Immunological Disorders
        5.1.5 Infectious Diseases
        5.1.6 Others
    5.2 By Application - Global Computational Drug Discovery Revenue & Forecasts
        5.2.1 By Application - Global Computational Drug Discovery Revenue, 2018-2023
        5.2.2 By Application - Global Computational Drug Discovery Revenue, 2024-2029
        5.2.3 By Application - Global Computational Drug Discovery Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Computational Drug Discovery Market Size, 2022 & 2029
    6.2 By Region - Global Computational Drug Discovery Revenue & Forecasts
        6.2.1 By Region - Global Computational Drug Discovery Revenue, 2018-2023
        6.2.2 By Region - Global Computational Drug Discovery Revenue, 2024-2029
        6.2.3 By Region - Global Computational Drug Discovery Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Computational Drug Discovery Revenue, 2018-2029
        6.3.2 US Computational Drug Discovery Market Size, 2018-2029
        6.3.3 Canada Computational Drug Discovery Market Size, 2018-2029
        6.3.4 Mexico Computational Drug Discovery Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Computational Drug Discovery Revenue, 2018-2029
        6.4.2 Germany Computational Drug Discovery Market Size, 2018-2029
        6.4.3 France Computational Drug Discovery Market Size, 2018-2029
        6.4.4 U.K. Computational Drug Discovery Market Size, 2018-2029
        6.4.5 Italy Computational Drug Discovery Market Size, 2018-2029
        6.4.6 Russia Computational Drug Discovery Market Size, 2018-2029
        6.4.7 Nordic Countries Computational Drug Discovery Market Size, 2018-2029
        6.4.8 Benelux Computational Drug Discovery Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Computational Drug Discovery Revenue, 2018-2029
        6.5.2 China Computational Drug Discovery Market Size, 2018-2029
        6.5.3 Japan Computational Drug Discovery Market Size, 2018-2029
        6.5.4 South Korea Computational Drug Discovery Market Size, 2018-2029
        6.5.5 Southeast Asia Computational Drug Discovery Market Size, 2018-2029
        6.5.6 India Computational Drug Discovery Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Computational Drug Discovery Revenue, 2018-2029
        6.6.2 Brazil Computational Drug Discovery Market Size, 2018-2029
        6.6.3 Argentina Computational Drug Discovery Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Computational Drug Discovery Revenue, 2018-2029
        6.7.2 Turkey Computational Drug Discovery Market Size, 2018-2029
        6.7.3 Israel Computational Drug Discovery Market Size, 2018-2029
        6.7.4 Saudi Arabia Computational Drug Discovery Market Size, 2018-2029
        6.7.5 UAE Computational Drug Discovery Market Size, 2018-2029
7 Computational Drug Discovery Companies Profiles
    7.1 AMRI
        7.1.1 AMRI Company Summary
        7.1.2 AMRI Business Overview
        7.1.3 AMRI Computational Drug Discovery Major Product Offerings
        7.1.4 AMRI Computational Drug Discovery Revenue in Global Market (2018-2023)
        7.1.5 AMRI Key News & Latest Developments
    7.2 Charles River
        7.2.1 Charles River Company Summary
        7.2.2 Charles River Business Overview
        7.2.3 Charles River Computational Drug Discovery Major Product Offerings
        7.2.4 Charles River Computational Drug Discovery Revenue in Global Market (2018-2023)
        7.2.5 Charles River Key News & Latest Developments
    7.3 Schrödinger
        7.3.1 Schrödinger Company Summary
        7.3.2 Schrödinger Business Overview
        7.3.3 Schrödinger Computational Drug Discovery Major Product Offerings
        7.3.4 Schrödinger Computational Drug Discovery Revenue in Global Market (2018-2023)
        7.3.5 Schrödinger Key News & Latest Developments
    7.4 Evotec
        7.4.1 Evotec Company Summary
        7.4.2 Evotec Business Overview
        7.4.3 Evotec Computational Drug Discovery Major Product Offerings
        7.4.4 Evotec Computational Drug Discovery Revenue in Global Market (2018-2023)
        7.4.5 Evotec Key News & Latest Developments
    7.5 Bayers
        7.5.1 Bayers Company Summary
        7.5.2 Bayers Business Overview
        7.5.3 Bayers Computational Drug Discovery Major Product Offerings
        7.5.4 Bayers Computational Drug Discovery Revenue in Global Market (2018-2023)
        7.5.5 Bayers Key News & Latest Developments
    7.6 GVK Biosciences
        7.6.1 GVK Biosciences Company Summary
        7.6.2 GVK Biosciences Business Overview
        7.6.3 GVK Biosciences Computational Drug Discovery Major Product Offerings
        7.6.4 GVK Biosciences Computational Drug Discovery Revenue in Global Market (2018-2023)
        7.6.5 GVK Biosciences Key News & Latest Developments
    7.7 AstraZeneca
        7.7.1 AstraZeneca Company Summary
        7.7.2 AstraZeneca Business Overview
        7.7.3 AstraZeneca Computational Drug Discovery Major Product Offerings
        7.7.4 AstraZeneca Computational Drug Discovery Revenue in Global Market (2018-2023)
        7.7.5 AstraZeneca Key News & Latest Developments
    7.8 BioDuro
        7.8.1 BioDuro Company Summary
        7.8.2 BioDuro Business Overview
        7.8.3 BioDuro Computational Drug Discovery Major Product Offerings
        7.8.4 BioDuro Computational Drug Discovery Revenue in Global Market (2018-2023)
        7.8.5 BioDuro Key News & Latest Developments
    7.9 BOC Sciences
        7.9.1 BOC Sciences Company Summary
        7.9.2 BOC Sciences Business Overview
        7.9.3 BOC Sciences Computational Drug Discovery Major Product Offerings
        7.9.4 BOC Sciences Computational Drug Discovery Revenue in Global Market (2018-2023)
        7.9.5 BOC Sciences Key News & Latest Developments
    7.10 Aris Pharmaceuticals
        7.10.1 Aris Pharmaceuticals Company Summary
        7.10.2 Aris Pharmaceuticals Business Overview
        7.10.3 Aris Pharmaceuticals Computational Drug Discovery Major Product Offerings
        7.10.4 Aris Pharmaceuticals Computational Drug Discovery Revenue in Global Market (2018-2023)
        7.10.5 Aris Pharmaceuticals Key News & Latest Developments
    7.11 ChemDiv
        7.11.1 ChemDiv Company Summary
        7.11.2 ChemDiv Business Overview
        7.11.3 ChemDiv Computational Drug Discovery Major Product Offerings
        7.11.4 ChemDiv Computational Drug Discovery Revenue in Global Market (2018-2023)
        7.11.5 ChemDiv Key News & Latest Developments
    7.12 RTI International
        7.12.1 RTI International Company Summary
        7.12.2 RTI International Business Overview
        7.12.3 RTI International Computational Drug Discovery Major Product Offerings
        7.12.4 RTI International Computational Drug Discovery Revenue in Global Market (2018-2023)
        7.12.5 RTI International Key News & Latest Developments
    7.13 XRQTC
        7.13.1 XRQTC Company Summary
        7.13.2 XRQTC Business Overview
        7.13.3 XRQTC Computational Drug Discovery Major Product Offerings
        7.13.4 XRQTC Computational Drug Discovery Revenue in Global Market (2018-2023)
        7.13.5 XRQTC Key News & Latest Developments
    7.14 Pharmaron
        7.14.1 Pharmaron Company Summary
        7.14.2 Pharmaron Business Overview
        7.14.3 Pharmaron Computational Drug Discovery Major Product Offerings
        7.14.4 Pharmaron Computational Drug Discovery Revenue in Global Market (2018-2023)
        7.14.5 Pharmaron Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Computational Drug Discovery Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?